The Japan Diabetes Society

JapaneseEnglish
SitemapSitemap

Vol.13 - No.1 (January 2022)

Vol.13 - No.1 (January 2022)

REPORT OF THE COMMITTEE

  Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity
A. Sasaki, K. Yokote, T. Naitoh, J. Fujikura, K. Hayashi, Y. Hirota, N. Inagaki, Y. Ishigaki, K. Kasama, E. Kikkawa, H. Koyama, H. Masuzaki, T. Miyatsuka, T. Nozaki, W. Ogawa, M. Ohta, S. Okazumi, M. Shimabukuro, I. Shimomura, H. Nishizawa, A. Saiki, Y. Seki, N. Shojima, M. Tsujino, S. Ugi, H. Watada, T. Yamauchi, T. Yamaguchi, K. Ueki, T. Kadowaki, I. Tatsuno, Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity 1-30
  Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity
A. Sasaki, K. Yokote, T. Naitoh, J. Fujikura, K. Hayashi, Y. Hirota, N. Inagaki, Y. Ishigaki, K. Kasama, E. Kikkawa, H. Koyama, H. Masuzaki, T. Miyatsuka, T. Nozaki, W. Ogawa, M. Ohta, S. Okazumi, M. Shimabukuro, I. Shimomura, H. Nishizawa, A. Saiki, Y. Seki, N. Shojima, M. Tsujino, S. Ugi, H. Watada, T. Yamauchi, T. Yamaguchi, K. Ueki, T. Kadowaki, I. Tatsuno, Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity 31-32
  Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity
A. Sasaki, K. Yokote, T. Naitoh, J. Fujikura, K. Hayashi, Y. Hirota, N. Inagaki, Y. Ishigaki, K. Kasama, E. Kikkawa, H. Koyama, H. Masuzaki, T. Miyatsuka, T. Nozaki, W. Ogawa, M. Ohta, S. Okazumi, M. Shimabukuro, I. Shimomura, H. Nishizawa, A. Saiki, Y. Seki, N. Shojima, M. Tsujino, S. Ugi, H. Watada, T. Yamauchi, T. Yamaguchi, K. Ueki, T. Kadowaki, I. Tatsuno, Joint Committee in the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, the Japan Society for the Study of Obesity 33-34

COMMENTARY

  Metformin action in the gut-insight provided by [18F]FDG PET imaging
H. Tsuchida, Y. Morita, M. Nogami, W. Ogawa 35-40

REVIEW ARTICLES

  Understanding the quality of diabetes care in Japan: a systematic review of the literature
J. Mitri, T. Sugiyama, H. Tanaka, M. Ohsugi, R.A. Gabbay 41-48
  The forgotten type 2 diabetes mellitus medicine: rosiglitazone
B. Xu, A. Xing, S. Li 49-65

ORIGINAL ARTICLES

  Study on the effects of changes in lifestyle of patients with diabetes on glycaemic control before and after the declaration of the state of emergency in Japan
M. Masuda, O. Tomonaga 66-74
  A randomized controlled trial of a structured program combining aerobic and resistance exercise for adults with type 2 diabetes in Japan
Y. Terauchi, T. Takada, S. Yoshida 75-84
  The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study
Y. Hosomi, C. Munekawa, Y. Hashimoto, T. Okamura, F. Takahashi, R. Kawano, H. Nakajima, S. Majima, T. Senmaru, N. Nakanishi, E. Ushigome, M. Hamaguchi, M. Yamazaki, M. Fukui 85-90
  Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control
H. Ito, R. Araki, S. Matsumoto, T. Izutsu, E. Kusano, J. Kondo, H. Inoue, S. Antoku, T. Yamasaki, T. Mori, M. Togane 91-100
  Prevalence and predictors of atrial fibrillation in Japanese patients with type 2 diabetes
S. Otake, A. Sato, T. Babazono 101-107
  Evaluation of perceived fears of COVID-19 virus infection and its relationship to health-related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single-center study
M. Abdelghani, M.G. Hamed, A. Said, E. Fouad 108-116
  Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes
M. Sakamoto, Y. Goto, A. Nagayama, M. Yano, S. Sato, Y. Tajiri, M. Nomura 117-123
  Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial
F. Yoshikawa, H. Uchino, T. Nagashima, S. Usui, M. Miyagi, Y. Ando, T. Hirose 124-131
  Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60)
K. Kawai, J. Eiki, A. Kanatsuka, S. Motohashi, A. Wakana, A. Hayashi, K. Iglay, K. Yamazaki, S. Tokita, H. Maegawa on behalf of Japan Diabetes Clinical Data Management Study Group (JDDM) 132-141
  Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background
F. Yoshikawa, N. Kumashiro, F. Shigiyama, M. Miyagi, Y. Ando, H. Uchino, T. Hirose 142-147
  Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria
S. Akazawa, E. Sadashima, Y. Sera, N. Koga 148-159
  Variables associated with adherence to the treatment of type 2 diabetes mellitus among elderly people
R.E. Machado de Oliveira, J.M. Ueta, L.J. Franco 160-168
  Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2
K. Arai, T. Nishikawa, S. Shirabe, Y. Matsuzawa, S. Ohtsu, S. Yuasa, K. Hirao, H. Mori 169-176
  A cross-sectional study of the correlation between diabetic therapy and serum zinc concentrations
M. Sakurai, J. Sasaki, H. Suwanai, J. Shikuma, R. Ito, M. Odawara, T. Miwa, R. Suzuki 177-187
  Cut-off values and clinical efficacy of body roundness index and other novel anthropometric indices in identifying metabolic syndrome and its components among Southern-Indian adults
C.K. Endukuru, G.S. Gaur, Y. Dhanalakshmi, J. Sahoo, B. Vairappan 188-200
  Association of a SNP in the IAPP gene and hyperglycemia on β-cell dysfunction in type 2 diabetes: the Toon Genome Study
R. Kawamura, Y. Tabara, Y. Takata, K. Maruyama, M. Takakado, T. Hadate, Y. Matsushita, M. Sano, H. Makino, I. Saito, A. Kanatsuka, H. Osawa 201-208
  Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial
S. Ogawa, Y. Ohsaki, M. Shimizu, K. Nako, M. Okamura, S. Kabayama, K. Tabata, Y. Tanaka, S. Ito 209-219
  Association of family history of type 2 diabetes with blood pressure and resting heart rate in young normal weight Japanese women
M. Honda, A. Tsuboi, S. Minato-Inokawa, K. Kitaoka, M. Takeuchi, M. Yano, M. Kurata, B. Wu, T. Kazumi, K. Fukuo 220-225
  Glycated albumin (GA) and the GA/HbA1c ratio are higher in diabetic patients positive for insulin antibodies with high binding capacity and low affinity
T. Takeuchi, Y. Hirota, Y. Nakagawa, A. Matsuoka, T. Hamaguchi, Y. Okada, K. Sakaguchi, W. Ogawa, M. Koga 226-231
  Explaining the obesity paradox in healthcare utilization among people with type 2 diabetes
V. Kumar, W. Encinosa 232-243
  Glycemic control and number of natural teeth: analysis of cross-sectional Japanese employment-based dental insurance claims and medical check-up data
K. Harada, K. Morino, M. Ishikawa, I. Miyazawa, T. Yasuda, M. Hayashi, A. Ishikado, H. Maegawa 244-252
  Work-related factors related to forgetting to take oral diabetes medication during the working day among Japanese male employees with diabetes
N. Sonoda, S. Watanabe, Y. Ohno, C. Hatamochi, Y. Sugimoto, M. Shikama, M. Li, A. Morimoto 253-261
  Tailored notification encouraging examinees with abnormal glucose levels in health checkups to seek medical care
M. Nagafuchi, H. Takahashi, K. Anzai, M. Hidaka, T. Matsushita, K. Fujita 262-271
  Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types
T. Takai, Y. Okada, R. Takebe, T. Nakamura 272-279
  A sensor augmented pump may improve awareness of hypoglycemia and quality of life in Japanese patients with type 1 diabetes mellitus
S. Takagi, J. Miura, K. Shimura, S. Hoshina, Y. Tsuchida, M. Takita, S. Mochizuki, Z. Shen, T. Asanuma, H. Takaike, T. Babazono 280-287
  Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design
D. Chujo, A. Imagawa, K. Yasuda, N. Abiru, T. Awata, T. Fukui, H. Ikegami, E. Kawasaki, T. Katsuki, T. Kobayashi, J. Kozawa, K. Nagasawa, H. Ohtsu, Y. Oikawa, H. Osawa, A. Shimada, M. Shimoda, K. Takahashi, K. Tsuchiya, T. Tsujimoto, H. Yasuda, T. Hanafusa, H. Kajio 288-294

CASE REPORTS

  Hypoglycemic coma in an elderly adult switched from twice-daily vildagliptin to once-daily glimepiride to improve drug adherence
S. Tominari, M. Yasuda, T. Kato, M. Sakai, S. Kubota, K. Nonomura, T. Hirose, K. Takao, Y. Liu, M. Mizuno, T. Hirota, K. Iizuka, T. Suwa, Y. Horikawa, D. Yabe 295-299
  Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report
Y. Kurokawa, Y. Oikawa, A. Shimada, K. Yajima 300-303
  Changes in glucagon secretion induced by food intake in fulminant type 1 diabetes mellitus: a case report
N. Himeno, T. Matsuda, M. Yoneda 304-308
  Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes
A. Kanzaki, M. Matsuda, S. Yokota, K. Takai, J. Murai, A. Otsuka, H. Koyama, T. Nakamura 309-313
  Correction to: Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes
A. Kanzaki, M. Matsuda, S. Yokota, K. Takai, J. Murai, A. Otsuka, H. Koyama, T. Nakamura 314
  Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report
D. Avramidou, P. Violatzi, D.G. Zikoudi, A. Mourseloglou, S. Panagaris, E. Metaxa, A. Partsalidis, I. Feresiadis, C. Savva, V. Papadopoulos 315-319
  Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report
T. Anno, F. Minakawa, R. Shigemoto, F. Kawasaki, K. Ishii, H. Kawamoto, K. Tomoda, K. Kaku, H. Kaneto 320-324

SHORT COMMUNICATIONS

  Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
F. Barkas, G. Anastasiou, H. Milionis, E. Liberopoulos 325-329
  A case of α-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay
K. Yoshino, Y. Hirota, W. Ogawa, K. Sugawara, A. Kawaguchi, H. Yoshino, M. Ishibashi, G. Yoshino, M. Koga 330-335

CORRECTION

  Correction to: Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake
H. Watanabe, M. Takahara, N. Katakami, T. Matsuoka, I. Shimomura 336

Update: January 11, 2022

SUB MENU